March 3, 2022:
Come to the Vascular Society of NJ Spring Meeting and celebrate @FrankCaputoMD’s triumphant return to the Garden State where he will give our keynote lecture on Aortic Surgery in the 21st Century!
Trainees/students attend free
Register at https://t.co/b91xF0Zq9y
Something about a certain road paved with good intentions. I (nor USPTF) am not aware of any evidence that screening for PAD reduces costs, anxiety, or amputations in any population. There is ample evidence that overtreating “low grade” PAD leads to CLTI and, thus, amputation. 1/
COVID 19 has limited our ability to have a visiting sub-internship, but we are excited to offer this alternative at @SinaiVascular for 4th year students looking for a vascular residency program.
Contact us!
@VouyoukaAgeliki BID xarelto will still cost my patients about $80/mo according to my local pharmacies. With apixaban recently becoming available as a generic, perhaps this could be a more practical alternative?